Intel's enhanced 18A-P has entered risk production, laying the groundwork to ramp the node into full production in the coming ...
The regulatory framework around biopharmaceutical manufacturing is exacting and continuously evolving. Companies must meet diverse global requirements while staying agile enough to deliver on ...